TGFB1 and COVID-19: COVID-19 plasma exosomes from patients later in their hospitalization induced the production of IL-6, TGFβ, and IL-10 compared with plasma exosomes from early-stage patients or non-COVID donors in Tregs (Fig. 3b, Supplementary Fig. S3c).